Analysis of knowledge about acute granular pharyngitis among Tiruchirapalli school children and their parents: connotation for preventing further complications
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20193090Keywords:
Pharyngitis, Children, Cross-sectional studyAbstract
Background: Identification and appropriate treatment for the streptococcal pharyngitis decreases the risk of acute rheumatic fever and rheumatic heart disease. By understanding the public perceptions and behaviors related to sore throat is considered as the fundamental for disseminating the health programs to control such diseases. The main objective of this study is to understand the epidemiology and microbiology of acute granular pharyngitis and its treatment in a tertiary care teaching hospital of South India.
Methods: This is a prospective and cross-sectional investigation performed by direct interview and written surveys. In this study, school students and their parents were interviewed about the history of sore throats in the last 12 months and treatment received. A focused history and physical examination to detect pharyngitis was conducted and children were referred for follow-up as indicated.
Results: A total of 1550 and 1450 students from 13 and 14 schools participated in the study respectively, along with their parents. Three hundred and thirty six (21.6%) parents reported their child had at least one episode of sore throat in the previous year, and 326 (21%) of students reported at least one sore throat in the same time period.
Conclusions: Girls were reported to have high level of pharyngitis than boys. Parents have variable knowledge about the frequency of sore throat in their children and its management. These results provide insight into current perceptions and practices related to sore throat and will be used to design public awareness activities aimed at reducing the future risks.
References
Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012;379:953-64.
Beaton A, Sable C. Health policy: reducing rheumatic heart disease in Africa - time for action. Nat Rev Cardiol. 2016;13:190-1.
GBD 2015 Disease and injury incidence and prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1545-602.
GBD 2016 Mortality and causes of death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;3e88:1459-544.
Beaton A, Okello E, Lwabi P, Mondo C, McCarter R, Sable C. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation. 2012;125:3127-32.
Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357:470-6.
Ngaide AA, Mbaye A, Kane A, Ndiaye MB, Jobe M, Bodian M, et al. Prevalence of rheumatic heart disease in Senegalese school children: a clinical and echocardiographic screening. Heart Asia. 2015;7:40-5.
Engel ME, Haileamlak A, Zuhlke L, Lemmer CE, Nkepu S, van de Wall M, et al. Prevalence of rheumatic heart disease in 4720 asymptomatic scholars from South Africa and Ethiopia. Heart 2015;101:1389-94.
Watkins D, Zuhlke L, Engel M, Daniels R, Francis V, Shaboodien G, et al. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communique. Cardiovasc J Afr. 2016;27:1-5.
Mayosi BM, Gamra H, Dangou JM, Kasonde J, 2nd All-Africa Workshop on Rheumatic Fever and Rheumatic heart disease participants. Rheumatic heart disease in Africa: the Mosi-o-Tunya call to action. Lancet Glob Health. 2014;2:438-9.
Zuhlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study) Eur Heart J. 2015;36:1115-22.
Kerdemelidis M, Lennon DR, Arroll B, Peat B, Jarman J. The primary prevention of rheumatic fever. J Paediatr Child Health 2010;46:534-48.
Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med. 2007;357:439-41.
Arguedas A, Mohs E. Prevention of rheumatic fever in Costa Rica. J Pediatr. 1992;121:569-72.
Nordet P, Lopez R, Duenas A, Sarmiento L. Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002) Cardiovasc J Afr. 2008;19:135-40.
Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM, World Heart F. Position statement of the world heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol 2013;10:284-92.
Robertson KA, Volmink JA, Mayosi BM. Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa-the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J. 2006;96:241-7.
Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009;119:1541-51.
Fine AM, Nizet V, Mandl KD. Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch Intern Med. 2012;172:847-52.
Eslami ST, Nassirian A, Nassirian H, Hatami E, Sobhani E, Najibpour R. Comparing performance of amoxicillin and intramuscular benzathine penicillin in relieving manifestations of streptococcal pharyngitis in children. Ghana Med J. 2014;48:185-8.
Cohen R, Estrangin E, Lecompte MD, Bouhanna CA, Wollner A, Koskas M, et al. Bacterial epidemiology of pharyngitis in pediatric private practice. Presse Med. 1994;23:1753-7.
John M, Joyce CL, Elizabeth M, Catherine J, Laurence C, Sherri S, et al. Epidemiology of pharyngitis as reported by Zambian school children and their families: implication for demand side interventions to prevent rheumatic heart disease. BMC Infect Dis. 2017;17:473-81.
Steer AC, Jenney AW, Kado J, Good MF, Batzloff M, Magor G, et al. Prospective surveillance of streptococcal sore throat in a tropical country. Pediatr Infect Dis J. 2009;28:477-82.
Kumar R, Vohra H, Chakraborty A, Sharma YP, Bandhopadhya S, Dhanda V, et al. Epidemiology of group A streptococcal pharyngitis and impetigo: a cross sectional and follow up study in a rural community of northern India. Ind J Med Res. 2009;130:765-71.
Rajkumar S, Krishnamurthy R. Isolation of group A β-hemolytic streptococci in the tonsillopharynx of school children in Madras city and correlation with their clinical features. Jpn J Infect Dis. 2001;54:137-9.
Nandi S, Kumar R, Ray P, Vohra H, Ganguly NK. Group A streptococcal sore throat in a periurban population of northern India: A one-year prospective study. Bull World Health Organ. 2001;79:528-33.
Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of streptococcus throat in adults in the emergency room. Med Decis Mak. 1981;1:239-46.
McIsaac WJ, McIsaac W, Goel V, To T, Low DE. The validity of a sore throat score in family practice. CMAJ. 2000;163:811-5.
Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child. 1972;124:352-8.
Singh AK, Kumar A, Agarwal L, Agarwal A, Sengupta C. Prevalence of group A streptococcal pharyngitis among schoolchildren of Barabanki district, Uttar Pradesh, India. J Acad Clin Microbiol. 2015;17:110-4.
